{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:01:34Z","timestamp":1793152894805,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.13386"],"award-info":[{"award-number":["2022.13386"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eururo.2025.01.013","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:15:21Z","timestamp":1738278921000},"page":"123-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives"],"prefix":"10.1016","volume":"88","author":[{"given":"Rui M.","family":"Bernardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.01.013_b0005","doi-asserted-by":"crossref","unstructured":"Bernardino RM, Yin LB, Lajkosz K, et al. Undetected cribriform and intraductal prostate cancer at biopsy is associated with adverse outcomes. Prostate Cancer Prostat Dis. In press. https:\/\/doi.org\/10.1038\/s41391-024-00910-3.","DOI":"10.1038\/s41391-024-00910-3"},{"key":"10.1016\/j.eururo.2025.01.013_b0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14737140.2018.1469406","article-title":"Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma","volume":"18","author":"Montironi","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.eururo.2025.01.013_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathol.2024.08.012","article-title":"Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional\/acinar prostatic adenocarcinoma","volume":"57","author":"Wang","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.eururo.2025.01.013_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","article-title":"Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer","volume":"10","author":"Bernardino","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.01.013_b0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/his.14867","article-title":"Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria","volume":"82","author":"Egevad","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2025.01.013_b0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/his.13878","article-title":"Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes","volume":"75","author":"Shah","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2025.01.013_b0035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/bju.16162","article-title":"Increasing trend of utilising active surveillance for Gleason score 7 (3 + 4) prostate cancer","volume":"132","author":"Bernardino","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.01.013_b0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s41379-022-01111-w","article-title":"Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification","volume":"35","author":"Yu","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2025.01.013_b0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.euf.2023.05.005","article-title":"Lymphotropic pattern of prostate-specific membrane antigen\u2013detected metastases among biochemically recurrent radical prostatectomy patients with cribriform disease","volume":"9","author":"Bernardino","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.01.013_b0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/JU.0000000000003850","article-title":"Intraductal prostate cancer affinity for lymphatic-predominant metastases through 18F-DCFPyL-prostate-specific membrane antigen-positron emission tomography\/CT scans in pretreatment prostate cancer patients","volume":"211","author":"Bernardino","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.01.013_b0055","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41467-022-33780-1","article-title":"Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease","volume":"13","author":"Wong","year":"2022","journal-title":"Nat Commun"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:38:34Z","timestamp":1778506714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0302283825000259"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.01.013","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}